title: Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation.
abstract: Macrophage phenotype and activation are regulated by cytokines that use the Jak-STAT signaling pathway, microbial recognition receptors that include TLRs, and immunoreceptors that signal via ITAM motifs. The amplitude and qualitative nature of macrophage activation are determined by crosstalk among these signaling pathways. Basal ITAM signaling restrains macrophage responses to TLRs and other activating ligands, whereas strong ITAM signals synergize with the same ligands to activate cells strongly. Similarly, basal ITAM signaling augments IFN signaling and function of receptor activator of NF-kappaB, but extensive ITAM activation inhibits Jak-STAT signaling. Thus, intensity and duration of ITAM signaling determine whether ITAM-coupled receptors augment or attenuate TLR and Jak-STAT responses. IFN-gamma synergizes with TLRs in part by suppressing TLR-induced feedback inhibition, mediated by IL-10 and Stat3, by a mechanism that depends on glycogen synthase kinase (GSK)3 regulation of AP-1 and CREB. IFN-gamma suppresses TLR2 and TLR4 induction/activation of AP-1 by overlapping mechanisms that include regulation of MAPKs, GSK3-dependent suppression of DNA binding, and decreased Fos and Jun protein expression and stability. IFN-gamma suppression of TLR-induced activation of AP-1 and downstream target genes challenges current concepts about the inflammatory role of AP-1 proteins in macrophage activation and is consistent with a role for AP-1 in the generation of noninflammatory osteoclasts. Jak-STAT, TLR, and ITAM pathways are basally active in macrophages and strongly induced during innate responses. Thus, signal transduction crosstalk is regulated in a dynamic manner, which differs under homeostatic and pathologic conditions, and dysregulation of signal transduction crosstalk may contribute to pathogenesis of chronic inflammatory diseases.
authors.affiliation: Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York 10021, USA.
authors.forename: Xiaoyu
authors.initials: X
authors.lastname: Hu
authors.forename: Janice
authors.initials: J
authors.lastname: Chen
authors.forename: Lu
authors.initials: L
authors.lastname: Wang
authors.forename: Lionel B
authors.initials: LB
authors.lastname: Ivashkiv
mesh_terms: D020816:Amino Acid Motifs; D000818:Animals; D006801:Humans; D053612:Janus Kinases / Q000235:genetics / Q000378:metabolism*; D008262:Macrophage Activation; D008264:Macrophages / Q000378:metabolism; D018448:Models, Immunological; D020239:Receptor Cross-Talk / Q000502:physiology*; D011971:Receptors, Immunologic / Q000235:genetics / Q000276:immunology; D050791:STAT Transcription Factors / Q000235:genetics / Q000378:metabolism*; D051193:Toll-Like Receptors / Q000276:immunology* / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism
chemical_list: D011971:Receptors, Immunologic; D050791:STAT Transcription Factors; D051193:Toll-Like Receptors; D014443:Tyrosine; D053612:Janus Kinases